The Infectious Disease Immunoassay Testing Market: Trends, Growth, and Future Outlook
Infectious Disease Immunoassay Testing Market: Trends, Growth and Future Outlook
The Infectious Disease Immunoassay Testing Market is expanding as healthcare systems adopt immunoassay technology to identify and monitor infectious diseases such as HIV, hepatitis, tuberculosis, influenza, COVID-19, and dengue.
The global market was valued at USD 8,850 million in 2025 and is expected to reach USD 13,480 million by 2035, with a CAGR of 4.30% from 2026 to 2035.
What Is Driving the Market?
The rising prevalence of infectious diseases is creating a high demand for accurate and accessible diagnostic testing. Immunoassay-based testing is rapidly being used by hospitals, diagnostic laboratories, blood banks, and public health agencies for disease screening, surveillance, and early detection.
Technologies such as ELISA, chemiluminescence immunoassay (CLIA), lateral flow immunoassays, and combination antigen/antibody testing provide faster and more efficient diagnosis.
Among technologies, ELISA had the biggest market share of 36.00% in 2025, with antibody testing accounting for 48.00% of the market by test type.
Rising Demand for Rapid and Point-of-Care Testing
The increased demand for speedier diagnostics is driving the use of rapid and point-of-care testing solutions. These technologies can be used for testing in hospitals, clinics, community settings, and other locations with minimal centralized laboratory infrastructure.
The demand is especially important for infectious diseases that necessitate large-scale screening and ongoing surveillance.
North America Leads the Market
North America had the highest share of 47.75% in 2025, with a regional market of around USD 4,226 million.
The region benefits from superior diagnostic infrastructure, significant healthcare spending, established biotechnology capabilities, and widespread use of automated testing platforms.
Asia Pacific is also emerging as a key growth area, accounting for 23.60% of the worldwide market by 2025. Regional potential are being boosted by increased healthcare investment, expanded diagnostic infrastructure, and rising infectious disease testing requirements.
Emerging Opportunities in Infectious Disease Testing
Automated immunoassay systems, multiplex testing, quick diagnoses, and better laboratory workflows are all becoming increasingly important in the future marketplace.
The combination of modern testing technology, digital healthcare, and increased disease surveillance has the potential to significantly improve diagnostic capacity, particularly in rising healthcare markets.
Future Outlook
The future of infectious disease immunoassay testing is projected to emphasize early detection, automation, rapid testing, high-throughput screening, and increased accessibility.
However, high infrastructure costs, regulatory restrictions, supply-chain problems, and disparities in healthcare access may continue to limit technology adoption in emerging nations.
Businesses, diagnostic manufacturers, healthcare providers, and investors will need to grasp these trends as infectious disease testing requirements grow.
Explore the Full Market Analysis.
Brandessence Market Research's Infectious Disease Immunoassay Testing Market Report provides thorough market projections, segmentation, geographical analysis, competition landscape, current trends, regulatory analysis, and strategic opportunities.
